Benefit-Risk Evaluation: The Past, Present And Future
A short article by Juhaeri JUHAERI, VP & Head, Epidemiology and Benefit-Risk at Sanofi Keywords:…
Why PV Should Be More Patient-Centric?
How has the pandemic been helping PV to integrate the patient centricity model? How to…
Patients Need the Right Information at the Right Time in the Right Format
Enhance the communication between PV professionals to become more aware of patients’ needs How to…
Pharmacogenomics – a Shifting Force in Drug Development Process
How identifying the genetic and non-genetic factors influence drug performance Why is it crucial to…
Transparent and Agile Pharmacovigilance Process During Pandemic
New approaches in BR assessment to improve your PV process What do transparent and robust…